FDA Regulatory Pathways for LNP(Lipid Nano Particle)-Based mRNA Therapeutics: Fast Track to Approval
Messenger RNA (mRNA)-based therapeutics have ushered in a new era of precision medicine. These t…
Messenger RNA (mRNA)-based therapeutics have ushered in a new era of precision medicine. These t…
The U.S. Food and Drug Administration (FDA) has released findings from an independent review of …
Medical devices are integral to modern healthcare, ranging from simple tools like bandages to ad…
A De Novo classification request provides a marketing pathway for novel medical devices for whic…
A PMA (Pre-Market Approval) Class III medical device represents the FDA's most stringent reg…
The International Medical Device Regulators Forum (IMDRF) recognizes that a global approach to a…
The Quality System Regulation (QSR) , outlined in Title 21 of the Code of Federal Regulations (2…
Here’s a quick guide to explore our content, join the community, and access resources for your regulatory journey.